ATELVIA DR 35 MG TABLET

risedronate sodium
$63.2246per EA
High Outlier

Strength

30.1; 4.9 mg/1; mg/1

Manufacturer

Allergan, Inc.

NDC

00430097903

Classification

Brand

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Last Updated

2/18/2026

Approval Type

New Drug (NDA)

FDA Application

NDA022560

On Market Since

12/1/2010

Pharmacological Classes

Bisphosphonate
Bisphosphonate
Diphosphonates
Diphosphonates

Price History

1W

0.0%

1M

0.0%

3M

-0.7%

6M

-0.7%

1Y

-1.1%

3Y

-0.8%

5Y

-0.8%

All

+80.3%

Generic Alternatives

Save up to 58%

1 alternative • Same active ingredient